Published by Josh White on 25th September 2023
(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.
URL: http://www.digitallook.com/dl/news/story/33791178/...